DatasetName,HSPA5_S(354) HSPA5_S(571) HSPA5_S(632) HSPA5_S(637) HSPA5_T(139) HSPA5_T(460) HSPA5_Y(160),HSPA5_S(301) HSPA5_S(340) HSPA5_S(4) HSPA5_S(448) HSPA5_S(455) HSPA5_S(86) HSPA5_T(4) HSPA5_T(518) HSPA5_T(525) HSPA5_T(648) HSPA5_T(85)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,,0.5245169724740951
FSO2013_Ratio M/L normalized Rep3,,0.5290196479715271
SR2019_MCF7_Biol_repl_3,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,
SR2019_LM2_Biol_repl_1,,
RCJD2014_15min_1,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,,
NJH2025_Sub12_HIIT_Mid,0.4376117357388893,0.5214761155096238
AH2018_LFQ_IT_1_C,,
RKK2015_TNF-α/basal,,
JJ2018_Ratio H/M normalized pP2,,
NJH2025_Sub12_MICT_Pre,0.4427956365372473,0.5346679386913026
NJH2025_Sub7_MICT_Post,,0.5304649746471566
DL2023_control-3,,
ZX2022_Control Replicate 2,,
HS2024_6_B_T3,,
JW2015_Intensity pre1,,0.5089637383756562
IMM2018_normalised rep. int. Empty-3,,
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,,0.520869321912385
SR2019_MDAMB231_Biol_repl_4,,
GF2025_P2_Sph,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,0.43084569895155267,0.499769570378732
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,0.5285122284719787
KBE2022_Log2_Ex_44_T,,
DB2022_Intensity L2,,
TM2022_mock.4h.C,,
AST2020_anti-CD3.2,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,0.43978031498591863,0.5192955972537724
FSO2013_Ratio M/L normalized Rep1___1,,0.5209330443067602
SAS2015_AZD/DMSO_Exp3,,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,0.4700132992259242,0.528855099599962
RB2022_5_PreEndurance,,0.5314723280423119
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,
EP2017_Untreated R#4 normalized log2 ratio,,
WZ2023_Pu_010_30min,,
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,,0.5244599946359899
NJH2024_Sub4_MICT_Post,0.44460474837120684,0.5325250970397963
AH2018_LFQ_M_1_X,,
RB2022_8_RecoveryEndurance,0.4279949389595861,0.5116398301728814
KBE2022_Log2_Ex_14_U,,
FSO2013_Ratio M/L normalized Rep3___3,,
AH2018_TMTMS3_1_C,,
JJ2018_Ratio H/L normalized___1,,
ZQ2022_C2,,
RB2022_5_PreSprint,,0.5258279156199606
PG2020_Intensity 8h_C,,
AH2018_SILAC_MR_2_N,,
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,0.5282499139995243
NJH2025_Sub7_MICT_Mid,,0.5310630678935868
LY2019_P1+,,
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),,
UK2020_HCM_2,,
FSO2013_Ratio H/L normalized Rep2___2,,
EP2017_Pervanadate R#3 normalized log2 ratio,,
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,,0.523557208858169
NJH2024_Sub4_MICT_Mid,0.4454558726932793,0.5321500869618863
TM2022_S2.4h.A,,
RB2022_5_PostStrength,,0.5167914340541053
GF2025_P6_Sph,,
RB2022_2_PreSprint,,0.5325185837802343
ZX2022_CB treated Replicate 3,,
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,,
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,,
KBE2022_Log2_Ex_34_U,,
WZ2023_Pu_005_10min,,
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,0.5278508377488218
CK2022_9 40-1,,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,,
WZ2023_Pu_025_30min,,
AH2018_SILAC_MR_2_X,,
HS2024_4_PD_T2,0.44685877053701784,0.5140364016701727
NJH2024_Sub4_HIIT_Pre,0.4444654366410238,0.5319121584640517
RB2022_2_RecoverySprint,,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,,
FR2021_Norm.Intensity.B,,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,
RB2022_5_PostSprint,,0.5248395348620405
EJN2021_3_Rest_Basal,0.4488606720390043,0.5269021178703176
CR2017_Ratio Replicate 1.3,,
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,,
JJ2018_Ratio M/L normalized pP3,,
AH2018_SILAC_M_2_N,,
HS2024_7_PD_T2,,
FSO2013_Ratio H/L normalized Rep1___1,,0.5290758173647235
AH2018_LFQ_1_C,,
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,,
HS2024_3_B_N1,,
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,,
CK2022_11 40-1,,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,,
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,0.4442668004041557,
FSO2013_Ratio H/L normalized Rep2,,0.5195969946698525
WZ2023_Pu_005_20min,,
NJH2024_Sub10_MICT_Post,0.422762398538127,0.4881966999189586
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,,
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,,
NJH2025_Sub7_MICT_Pre,,0.5306754872079975
SR2019_SKBR3_Biol_repl_2,,
HS2024_9_B_T2,,
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,,
FSO2013_Ratio M/L normalized Rep3___2,,
SR2019_BT549_Biol_repl_3,,
RCJD2014_20min_mean,,
FR2021_Norm.Intensity.H,,
RB2022_2_PreStrength,,0.5225052442636818
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,0.44684397646308577,0.5244908499697085
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,,
CK2022_1 200-1,,
PG2020_Intensity Mock_10h_D,,
SR2019_MCF10A_Biol_repl_2,,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,
RB2022_6_RecoveryEndurance,,0.5266830441692826
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,,
RCJD2014_5min_1,,
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,,
SAS2015_PLX/AZD_Exp2,,
CR2017_Ratio Replicate 3.3,,
PG2020_Intensity 2h_C,,
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,,
KBE2022_Log2_Ex_8_T,,
NJH2025_Sub10_MICT_Post,0.422762398538127,0.4881966999189586
HS2024_6_I_T3,,
RN2012_L11,,
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,,
HS2024_5_PD_T1,,
AH2018_LFQ_M_2_C,,
CK2022_3 40-1,,
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,0.4459554885446195,0.5294859873491155
HS2024_4_I_T1,,
YA2020_Reporter_intensity_Cancer_No.5,,0.5281992028696455
HH2022_Reporter intensity 8,,
ZQ2022_N2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,,
EJN2021_5_Rest_Basal,0.436241461632549,0.5302655676561012
NJH2025_Sub2_HIIT_Post,,0.5043346232361148
NJH2025_Sub1_MICT_Post,,0.5106188586740887
HS2024_9_B_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,
NJH2024_Sub6_HIIT_Pre,,0.5153091787901988
AH2018_SILAC_3_N,,
YA2020_Reporter_intensity_Normal_No.1,,0.5256451095656313
HS2024_3_B_T1,,
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,0.4423483104860658,0.525693071035979
RB2022_1_PostEndurance,,0.4955931241733129
CR2017_Ratio Replicate 3,,
SR2019_Hs578T_Biol_repl_3,,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,0.4227239828613815,0.5141225309360474
NJH2024_Sub13_MICT_Mid,0.4425022637653383,0.5299769063614689
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,,
HS2024_8_I_T3,,
CF2017_EOC 3,,0.5365137949591278
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,
HS2024_6_PD_T3,,
DL2023_12h-2,,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,,
WZ2023_Pu_010_20min,,
AS2011_Ratio H/L_3,,
CK2022_1 40-1,,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,,
KS2014_Intensity N3,0.42501794957361144,
RB2022_4_RecoveryEndurance,,0.5283019918935846
RB2022_5_RecoveryEndurance,,0.5345007204928944
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,0.4376117357388893,0.5214761155096238
AH2018_LFQ_IT_1_N,,
FSO2013_Ratio H/M normalized Rep2,,0.5200961734159507
RAM2015_Log2 A,,
HS2024_8_PD_T1,,
JJ2018_Ratio H/L normalized pP2,,
CF2017_OSE 27,,
KS2014_Intensity E15_2,0.43460582275437737,
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,,
HS2024_7_I_T1,,
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,,
SR2019_JIMT1_Biol_repl_1,,
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,,
AH2018_SILAC_M_3_X,,
NJH2024_Sub9_HIIT_Post,,0.5260616369340987
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,0.5043364766586158
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,
NJH2024_Sub4_HIIT_Mid,0.43548449065650796,0.5190810652464237
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,,
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,0.4576187980913894,0.5160624015152425
NJH2025_Sub4_MICT_Mid,0.4454558726932793,0.5321500869618863
YP2020_Intensity C30_R1_mult_log2,,0.5219778809876078
AST2020_anti-CD3.1,,
NJH2025_Sub4_HIIT_Post,0.4459554885446195,0.5294859873491155
EP2017_Untreated R#4 log2 ratio,,
HS2024_6_B_N1,,
KBE2022_Log2_Ex_27_T,,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,0.5285122284719787
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,0.5246039093461372
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,0.44129075662621525,0.5306562369468474
AH2018_SILAC_IT_3_X,,
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,,
FSO2013_Ratio M/L normalized Rep2,,0.5310016242167016
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,,
SR2019_HCC1954_Biol_repl_2,,
CK2022_14 40-1,,
RB2022_6_PreSprint,,0.5305066991000064
NJH2025_Sub12_MICT_Mid,0.4427579345362766,0.5327843748762456
PG2020_Intensity 4h_D,,
NJH2025_Sub2_MICT_Post,,0.5358777551398182
AH2018_LFQ_4_C,,
DL2023_control-1,,
AR2021_ALG 10 μM,,
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,,
EJN2021_4_Rest_Ins,0.4381378202052499,0.5295594398018447
RN2012_H05,,
NJH2024_Sub7_HIIT_Mid,,0.5291850400731516
GF2025_P2_Adh,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,0.4502581182539462,0.5326323618846928
EJN2021_1_Rest_Ins,0.4313042857277857,0.5255638355123843
HH2022_Reporter intensity 3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,,
JW2021_After_3,,
GF2025_P8_Sph,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,,
AH2018_SILAC_2_N,,
CK2022_11 200-1,,
CK2022_12 200-1,,
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,0.5113741682632379
HH2022_Reporter intensity 9,,
WZ2023_Su_010_20min,,
AH2018_TMTMS2_2_N,,
NJH2024_Sub13_MICT_Pre,0.4420206739077141,0.5259072856650046
KBE2022_Log2_Ex_41_U,,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,0.5169890517783667
AH2018_TMTMS3_Pool,,
KS2014_Intensity N4,0.4231340762595909,
NJH2024_Sub1_HIIT_Post,,0.5114138530257649
MM2018_Ratio H/L replicate2,,
RM2024_Intensity D4-2___2,,0.5176341838917075
NJH2024_Sub13_HIIT_Pre,0.440558112106451,0.5249744380070726
CF2017_OSE 26,,
CK2022_14 200-1,,
SR2019_Hs578T_Biol_repl_1,,
RB2022_7_PostSprint,0.4543061162387299,0.5219703807200475
TM2022_mock.4h.A,,
NJH2025_Sub12_HIIT_Pre,0.4447323624128012,0.5344458120457426
AH2018_TMTMS3_1_N,,
AST2020_anti-CD3+PDL2.2,,
PG2020_Intensity Mock_10h_A,,
JW2021_After_2,,
NJH2024_Sub2_MICT_Post,,0.5358777551398182
EJN2021_2_Rest_Ins,0.4316563242781082,0.530426229128585
SR2019_LM2_Biol_repl_4,,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,,
GF2025_P1_Adh,,
GF2025_P1_Sph,,
EJN2021_5_Ex_Basal,0.4363950467808517,0.5257838427655073
HS2024_7_I_T3,,
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,,
CF2017_EOC 1,,0.541797742714066
CK2022_3 200-1,,
AH2018_LFQ_IT_3_C,,
SR2019_Hs578T_Biol_repl_2,,
NJH2024_Sub12_HIIT_Post,0.44546555987962505,0.5328728410536119
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,0.4308490142452553,0.5086259145886309
NJH2024_Sub13_MICT_Post,0.4414315028195478,0.5262034616697605
BS2014_Log2(Ratio H/L normalized Rep_1),,
RB2022_3_RecoverySprint,0.4679909487067997,0.5150931441955552
NJH2025_Sub1_HIIT_Mid,,0.5117916422658833
RCJD2014_20min_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,,
HS2024_5_B_T1,,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,,
SR2019_MDAMB231_Biol_repl_2,,
HS2024_3_B_T2,,
RB2022_6_PreStrength,,0.5253954642835
CK2022_2 40-1,,
RB2022_1_PostSprint,,0.5274774203521845
CK2022_4 200-1,,
JW2021_Before_2,,
TM2022_S2.12h.A,,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,,
AR2021_ALG 1 μM,,
HS2024_4_B_T1,,
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,,
EJN2021_1_Rest_Basal,0.4417325884647947,0.5304822568317219
NJH2025_Sub8_MICT_Post,0.4341440363716419,0.5147039836179416
RCJD2014_5min_3,,
CR2017_Ratio Replicate 3.2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,,
CK2022_9 16-1,,
NJH2024_Sub6_HIIT_Post,,0.5289172899471009
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,0.44482234649152824,
CK2022_13 200-1,,
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,,
CK2022_16 16-1,,
FS2019_db/db3,,
CK2022_15 40-1,,
NJH2024_Sub9_MICT_Pre,,0.5267775614902107
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,,
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,,
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,,
HS2024_5_PD_T3,0.43570455227140015,
AH2018_TMTMS3_3_X,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,,
AH2018_LFQ_M_1_N,,
KBE2022_Log2_Ex_27_U,,
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),,
AH2018_SILAC_M_1_N,,
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,,0.5267975162713212
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,0.45158447164014026,0.5270746810618273
YA2020_Reporter_intensity_Normal_No.4,,0.519734676360508
NJH2025_Sub13_HIIT_Pre,0.440558112106451,0.5249744380070726
PG2020_Intensity CT_D,,
NJH2025_Sub9_MICT_Post,,0.5280145397546053
VOI2024_Veh1 mono,,
CK2022_12 16-1,,
RN2012_L13,,
LG2023_Control-1_intensity,,
RM2024_Intensity D6-3___2,,0.5287896531703548
KBE2022_Log2_Ex_8_U,,
SR2019_SKBR3_Biol_repl_3,,
NJH2024_Sub1_MICT_Post,,0.5106188586740887
HS2024_3_I_T2,,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,0.4870373855751325,0.5481136812060515
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,,0.5213811019392645
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,,
NJH2024_Sub12_HIIT_Pre,0.4447323624128012,0.5344458120457426
NJH2024_Sub8_MICT_Pre,0.4316742585626456,0.5137923096555667
RM2024_Intensity D0-1___1,,0.52487204246272
LY2019_P3+,,
HH2022_Reporter intensity 6,,
RB2022_2_RecoveryStrength,,0.5245742886505772
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,,
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,,
AH2018_TMTMS2_3_X,,
GF2025_P3_Adh,,
SR2019_JIMT1_Biol_repl_2,,
AH2018_TMTMS2_1_C,,
RM2024_Intensity D0-1___2,,
LY2019_P4+,,
KBE2022_Log2_Ex_19_U,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,
RB2022_4_PostStrength,,0.5231084693653391
LG2023_GSK3α-3_intensity,,
YA2020_Reporter_intensity_Cancer_No.1,,0.5290212524666692
AST2020_Control,,
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,,0.509706801529197
TM2022_S2.12h.C,,
NJH2025_Sub9_MICT_Mid,,0.5304712991027939
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,,0.5305975647328199
LG2023_Control-2_intensity,,
NJH2024_Sub8_HIIT_Pre,0.43287891850458077,0.5155866394890054
KS2014_Intensity pY_N2,,
RB2022_5_RecoverySprint,,0.4972199383424819
RB2022_7_RecoverySprint,0.4412412786984314,
YA2020_Reporter_intensity_Normal_No.3,,0.5212006916167258
HS2024_8_B_T2,,
AH2018_LFQ_1_X,,
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,,
FR2021_Norm.Intensity.M,,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,0.43156090368004607,
HH2022_Reporter intensity 1,,
HH2022_Reporter intensity 2,,
RM2024_Intensity D6-2___2,,0.5279964374837198
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,,0.5215106795882007
SR2019_MCF7_Biol_repl_1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,0.45077492845801487,
NJH2025_Sub6_HIIT_Pre,,0.5153091787901988
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,,
SR2019_LM2_Biol_repl_3,,
RB2022_4_RecoveryStrength,,0.5289528099766512
CR2017_Ratio Replicate 2,,
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,,0.521578512693276
AR2021_KD 72h,,
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,,
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,0.4341440363716419,0.5147039836179416
AH2018_TMTMS3_3_C,,
KBE2022_Log2_Ex_9_U,,
AH2018_SILAC_M_3_N,,
KBE2022_Log2_Ex_13_T,,
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,,
PG2020_Intensity Mock_10h_C,,
CF2017_OSE 29,,0.5264868488434665
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,0.5114138530257649
DL2023_24h-2,,
HS2024_7_B_N2,0.4567462388618954,0.5521666718739339
PG2020_Intensity 10h_A,,
RN2012_L12,,
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,0.4326729128733707,0.5152312514621831
AH2018_LFQ_IT_4_C,,
SAS2015_PLX/AZD_Exp1,,
FR2021_Norm.Intensity.A,,
FSO2013_Ratio H/M normalized Rep1___1,,0.5202450224798323
JW2015_Intensity cap2,,0.5110175266512754
BS2014_Log2(Ratio H/L normalized Rep_2),,
NJH2024_Sub6_MICT_Post,,0.5299827177678745
CK2022_8 40-1,,
RB2022_7_RecoveryEndurance,0.44308275356699406,0.5242245379322413
NJH2025_Sub12_HIIT_Post,0.44546555987962505,0.5328728410536119
EJN2021_4_Ex_Basal,0.42571110473663315,0.5133498160019986
TM2022_S2.12h.B,,
RN2012_L15,,
KS2014_Intensity pY_PV3,0.4197887766546102,
TM2022_S2.4h.B,,
PG2020_Intensity 4h_A,,
FSO2013_Ratio H/M normalized Rep2___2,,
TM2022_mock.4h.B,,
KBE2022_Log2_Ex_24_U,,
NJH2025_Sub13_MICT_Mid,0.4425022637653383,0.5299769063614689
KS2014_Intensity C3,0.4492564356886407,
RB2022_1_PreSprint,,0.531130815907427
HS2024_4_I_N1,,
CK2022_7 200-1,,
CK2022_5 200-1,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,
FSO2013_Ratio H/L normalized Rep2___1,,0.5196695139111016
NJH2024_Sub10_HIIT_Mid,0.423433135539449,0.492835649152873
RB2022_2_PostEndurance,,0.5304800495231947
AH2018_LFQ_2_C,,
AH2018_SILAC_MR_1_X,,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,,
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,,
AH2018_SILAC_3_C,,
EJN2021_5_Rest_Ins,0.4307368817418272,0.526491787239724
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,,0.5192615084775715
CK2022_4 16-1,,
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,,
EJN2021_2_Ex_Ins,0.42612480802352276,0.49412234212117023
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,,
SAS2015_PLX/DMSO_Exp1,,
SFR2015_HL_log2_ratio_avg_c,,
JJ2018_Ratio M/L normalized pP2,,
NJH2024_Sub7_MICT_Mid,,0.5310630678935868
PG2020_Intensity 6h_B,,
FSO2013_Ratio H/L normalized Rep3,,0.5122842687431364
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,
JJ2018_Ratio M/L normalized,,
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,,
NJH2025_Sub2_MICT_Mid,,0.5237096617245833
HS2024_6_B_N2,,
KBE2022_Log2_Ex_9_T,,
AH2018_SILAC_IT_2_N,,
AH2018_SILAC_IT_1_X,,
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,,
UK2020_UA_2,,
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,,
WZ2023_Pe_025_20min,,
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,
AH2018_LFQ_2_N,,
HS2024_4_I_N2,,
AH2018_TMTMS2_3_N,,
RN2012_H06,,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,0.45069245835739086,0.529087669921926
WZ2023_Su_005_30min,,
SR2019_HCC1419_Biol_repl_4,,
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,,
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,,
NJH2024_Sub10_HIIT_Post,0.4215122199486401,0.489989086071199
CR2017_Ratio Replicate 3.1,,
WZ2023_Su_025_10min,,
AH2018_LFQ_IT_4_X,,
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,,0.5242663018000805
RM2024_Intensity D6-3,,0.524496802940909
WZ2023_Su_005_20min,,
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,,0.52700931506775
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,,
EP2017_Pervanadate R#1 log2 ratio,,
NJH2025_Sub6_HIIT_Post,,0.5289172899471009
RB2022_6_RecoverySprint,,0.48555272829509816
KS2014_Intensity,,
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,,
LY2019_P7+,,
EP2017_Untreated R#1 normalized log2 ratio,,
RN2012_L10,,
PG2020_Intensity 4h_C,,
EP2017_Mitotic R#3 normalized log2 ratio,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,,
RB2022_8_PostStrength,,0.5160752133852368
AH2018_SILAC_IT_2_X,,
HS2024_4_B_T3,,
NJH2024_Sub2_HIIT_Post,,0.5043346232361148
HS2024_8_B_N2,0.43482706293638884,
NJH2025_Sub8_HIIT_Pre,0.43287891850458077,0.5155866394890054
JJ2018_Ratio H/L normalized pP2___1,,
HS2024_8_I_T2,,
KBE2022_Log2_Ex_6_U,,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,
CR2017_Ratio Replicate 1.1,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,,
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,,
GF2025_P9_Sph,,
CK2022_6 200-1,,
NJH2024_Sub7_MICT_Post,,0.5304649746471566
AH2018_TMTMS3_2_X,,
NJH2024_Sub8_HIIT_Post,0.4291905327751146,0.5107251368626421
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,,0.5157303337710292
SR2019_HCC1954_Biol_repl_1,,
HS2024_4_I_T2,,
NJH2024_Sub2_MICT_Mid,,0.5237096617245833
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,0.45492788750008256,0.5183871915248571
SAS2015_AZD/DMSO_Exp1,,
NJH2024_Sub1_MICT_Mid,,0.509706801529197
IMM2018_normalised rep. int. CDK5L-3,,
HS2024_3_B_T3,,
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,0.4420206739077141,0.5259072856650046
SR2019_MDAMB231_Biol_repl_3,,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,,
PG2020_Intensity 2h_D,,
EP2017_Untreated R#3 normalized log2 ratio,,
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,0.5303384550412181
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,,
KS2014_Intensity pY_C4,0.44571238241084304,
CR2017_Ratio Replicate 3.5,,
RB2022_7_PostEndurance,0.44191613963673504,0.5288020289364138
NJH2025_Sub4_HIIT_Pre,0.4444654366410238,0.5319121584640517
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,,
JJ2018_Ratio H/L normalized pP1,,
EP2017_Pervanadate R#2 normalized log2 ratio,,
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,
AH2018_SILAC_2_C,,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,0.48951702808836217,0.5540621540709059
KBE2022_Log2_Ex_29_T,,
HS2024_7_I_T2,,
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,,
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,,
EJN2021_1_Ex_Basal,0.4262185749028396,0.5266957344030325
FR2021_Intensity.M,,
RB2022_2_PostSprint,,0.5226163240787187
AH2018_SILAC_MR_3_N,,
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,,0.5167235030572193
PG2020_Intensity CT_C,,
ZCP2016_Ratio H/L Rep 1,,
FS2019_db/db2,,
KS2014_Intensity pY_PV4,0.4293256997150721,
KBE2022_Log2_Ex_39_U,,
EP2017_Untreated R#3 log2 ratio,,
RB2022_2_PostStrength,,0.5198214962937822
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,,
HS2024_8_PD_T2,,
FS2019_Ctr2,,
RB2022_6_PreEndurance,,0.5279469462407451
FR2021_Norm.Intensity.G,,
NJH2025_Sub9_HIIT_Post,,0.5260616369340987
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,
RM2024_Intensity D4-3,,0.5153244239973951
HS2024_8_B_N1,0.4387169362803493,
NJH2025_Sub10_MICT_Mid,0.4308490142452553,0.5086259145886309
KBE2022_Log2_Ex_15_U,,
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,,
RB2022_3_PreSprint,0.44885174619997653,0.5390350756231271
CR2017_Ratio Replicate 2.3,,
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,,
YA2020_Reporter_intensity_Normal_No.2,,0.5207152903460618
YP2020_Intensity P30_R2_mult_log2,,0.4963369178400187
NJH2025_Sub13_MICT_Post,0.4414315028195478,0.5262034616697605
HS2024_4_B_N2,0.41556303783815923,0.5255182693337226
HS2024_3_PD_T3,,
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,0.4242240713564534,0.4834182977166087
FR2021_Intensity.G,,
RAM2015_Log2 C,,
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,,
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,,
CK2022_2 16-1,,
RAM2015_Log2 B,,
YP2020_Intensity C10_R1_mult_log2,,0.5137124215116912
FSO2013_Ratio M/L normalized Rep1___2,,
NJH2025_Sub8_MICT_Pre,0.4316742585626456,0.5137923096555667
EJN2021_4_Rest_Basal,0.4336520658302168,0.5292521676024518
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,,
UK2020_HCM_5,,
NJH2025_Sub10_HIIT_Post,0.4215122199486401,0.489989086071199
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,,0.511805226519282
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,,
HS2024_7_PD_T3,0.44314048120674526,0.5256138214624363
PG2020_Intensity Mock_10h_B,,
WZ2023_Su_025_30min,,
AH2018_LFQ_4_N,,
CR2017_Ratio Replicate 1.2,,
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,,0.5275843056598642
HS2024_8_I_N1,0.4498294808194444,
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,,
AH2018_SILAC_M_1_X,,
RB2022_7_PreEndurance,0.44142127888909766,0.5198667969419744
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,,
LY2019_P6+,,
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,,
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,,
NJH2025_Sub7_HIIT_Mid,,0.5291850400731516
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,,0.5155281160461569
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,,
SR2019_Hs578T_Biol_repl_4,,
RB2022_8_PreStrength,0.453834613472829,0.5374433596594383
KS2014_Intensity C5,0.447258269867524,
RM2024_Intensity D0-1,,0.5204275944947719
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,,0.49313481083211763
NJH2025_Sub2_HIIT_Pre,,0.5328975580656904
RB2022_3_RecoveryEndurance,0.4369115600222545,0.5299324690508643
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,,
RB2022_3_PostStrength,,0.5193650561416522
TM2022_S2.8h.A,,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,0.534047043555012
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,,
SR2019_BT549_Biol_repl_1,,
AH2018_LFQ_M_4_N,,
NJH2024_Sub8_HIIT_Mid,0.4264887050389419,0.5129583290379752
PG2020_Intensity 8h_B,,
AH2018_LFQ_2_X,,
PG2020_Intensity 2h_B,,
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,,0.532214120650601
KS2014_Intensity E15_3,0.44287335931432353,
GF2025_P3_Sph,,
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,,
NJH2024_Sub1_HIIT_Pre,,0.5043364766586158
FSO2013_Ratio M/L normalized Rep2___2,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,0.519220122446259
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,,0.5275844134602837
JJ2018_Ratio M/L normalized pP1,,
CR2017_Ratio Replicate 2.4,,
ZQ2022_N1,,
LY2019_P6-,,
RM2024_Intensity D2-3,,
UK2020_HCM_1,,
JW2015_Intensity pre2,,0.5097059377998179
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,0.44275173104129883,0.5367662189116292
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,,
AH2018_LFQ_3_N,,
RKK2015_TNF-α/IKKb,,
SFR2015_HL_log2_ratio_std_b,,
UK2020_UA_1,,
KBE2022_Log2_Ex_13_U,,
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,,0.5042970837259199
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,
JJ2018_Ratio H/L normalized pP3,,
CK2022_7 40-1,,
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,0.423433135539449,0.492835649152873
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,,
SR2019_BT549_Biol_repl_2,,
RM2024_Intensity D4-2,,0.5190861412328261
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,,
RB2022_5_PostEndurance,,0.5251656351196341
HS2024_5_PD_T2,0.44316964163064154,
WZ2023_Su_025_20min,,
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,,
LY2019_P8-,,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,
FSO2013_Ratio H/L normalized Rep1,,0.5280085975943599
NJH2024_Sub2_HIIT_Pre,,0.5328975580656904
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,
CK2022_13 40-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,,
PG2020_Intensity 10h_D,,
RB2022_8_PreEndurance,0.444231761448917,0.529331015415012
HS2024_3_B_N2,,
EJN2021_4_Ex_Ins,0.427570992015888,0.5312829990725272
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,0.4181321684535054,0.5276550364480678
EP2017_Pervanadate R#3 log2 ratio,,
FSO2013_Ratio M/L normalized Rep1___3,,
NJH2025_Sub4_HIIT_Mid,0.43548449065650796,0.5190810652464237
RCJD2014_5min_2,,
RB2022_6_PostStrength,,0.522079052919508
AH2018_SILAC_MR_3_C,,
AH2018_LFQ_M_4_C,,
NJH2024_Sub4_MICT_Pre,0.43566773770185435,0.5199533810672912
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,,
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,0.5289522770214163
NJH2025_Sub6_MICT_Post,,0.5299827177678745
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,
RN2012_H04,,
CK2022_6 40-1,,
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,,
LY2019_P3-,,
FR2021_Intensity.A,,
EJN2021_3_Ex_Ins,0.4286000458261144,0.5306588224500817
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,,
HS2024_8_PD_T3,,
EJN2021_3_Ex_Basal,0.42182853611643173,0.530762370884971
AST2020_Control.1,,
JW2015_Intensity cap1,,0.5094971626835106
PG2020_Intensity CT_A,,
FS2019_Ctr3,,
WZ2023_Pu_025_20min,,
NJH2025_Sub4_MICT_Post,0.44460474837120684,0.5325250970397963
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,
GF2025_P10_Adh,,
RB2022_1_RecoveryStrength,,0.527411428612735
SR2019_HCC1954_Biol_repl_4,,
FR2021_Norm.Intensity.N,,
HS2024_5_B_N1,0.44409712880987434,
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,,
RB2022_4_PreSprint,,0.5304393094927263
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,,
HS2024_8_I_N2,0.44093775044022504,
RB2022_3_RecoveryStrength,0.4164904545978791,0.536821463743969
NJH2024_Sub6_HIIT_Mid,,0.529954424392506
AH2018_SILAC_M_1_C,,
LY2019_P8+,,
RB2022_2_RecoveryEndurance,,0.5282333794258096
JJ2018_Ratio H/M normalized pP2___1,,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,0.4506256761725568,0.5214096668353307
KS2014_Intensity pY_PV1,,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,0.52937569117851
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,,
NJH2024_Sub6_MICT_Pre,,0.5289522770214163
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,0.5195783271343065
NJH2024_Sub9_HIIT_Pre,,0.5274775809306662
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,,
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,,
LY2019_P2-,,
AH2018_LFQ_IT_1_X,,
JJ2018_Ratio H/L normalized pP3___1,,
RB2022_8_RecoveryStrength,,0.515130733768529
WZ2023_Pe_005_20min,,
AST2020_Control.2,,
NJH2025_Sub6_MICT_Mid,,0.5144466550184595
RCJD2014_10min_1,,
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,
HS2024_3_I_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,,
SR2019_MCF10A_Biol_repl_4,,
KS2014_Intensity pY_C5,0.44569452923489183,
NJH2025_Sub4_MICT_Pre,0.43566773770185435,0.5199533810672912
NJH2024_Sub9_MICT_Post,,0.5280145397546053
CF2017_OSE 28,,
HS2024_5_B_T2,,
HS2024_6_I_T1,,
HS2024_5_B_T3,,
JJ2018_Ratio H/M normalized pP1___1,,
KBE2022_Log2_Ex_36_U,,
AH2018_TMTMS3_3_N,,
SR2019_HCC1419_Biol_repl_2,,
FR2021_Intensity.N,,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,,
NJH2024_Sub1_HIIT_Mid,,0.5117916422658833
NJH2025_Sub8_HIIT_Mid,0.4264887050389419,0.5129583290379752
EP2017_Mitotic R#3 log2 ratio,,
KBE2022_Log2_Ex_36_T,,
NJH2025_Sub6_HIIT_Mid,,0.529954424392506
WZ2023_Pu_005_30min,,
KS2014_Intensity C2,0.4479072228989329,
FSO2013_Ratio H/L normalized Rep1___2,,
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,,
CK2022_9 200-1,,
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,,
NJH2024_Sub9_MICT_Mid,,0.5304712991027939
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,,
RBK2021_1332T Late,,
LY2019_P1-,,
RKK2015_TNF-α/basal.1,,
RKK2015_TNF-α/TNF-α+SC-514,,
CR2017_Ratio Replicate 2.5,,
HS2024_3_I_T3,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,0.43587936213802375,
ZQ2022_C3,,
EJN2021_3_Rest_Ins,0.42274879763492834,0.5347089562881401
YP2020_Intensity P10_R2_mult_log2,,0.518328818978415
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,0.5113741682632379
KBE2022_Log2_Ex_39_T,,
FSO2013_Ratio H/M normalized Rep3___2,,
RM2024_Intensity D6-2,,0.5251008450167599
EP2017_Untreated R#1 log2 ratio,,
RKK2015_SC-514/basal,,
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,,
NJH2025_Sub9_HIIT_Mid,,0.5278508377488218
SR2019_SKBR3_Biol_repl_4,,
HS2024_5_I_T3,,
KS2014_Intensity N1,0.4249536971082625,
NJH2024_Sub12_MICT_Post,0.44275173104129883,0.5367662189116292
TM2022_S2.8h.C,,
CR2017_Ratio Replicate 1,,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,
JJ2018_Ratio H/M normalized pP3,,
AH2018_SILAC_MR_2_C,,
LATM2013_Log2 Ratio (Medium/Light) Forward,,
PG2020_Intensity 2h_A,,
NJH2024_Sub6_MICT_Mid,,0.5144466550184595
NJH2025_Sub13_HIIT_Post,0.4369352256901916,0.5246423191802538
AH2018_SILAC_MR_3_X,,
JJ2018_Ratio H/M normalized___1,,
RCJD2014_15min_2,,
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,,
HS2024_5_B_N2,0.427481121905647,
HS2024_5_I_N1,0.43730954976358,
HS2024_6_I_N1,,
AR2021_KD 48h,,
FR2021_Intensity.B,,
RB2022_3_PreEndurance,0.44295933997397224,0.518204501159166
HS2024_5_I_T1,,
NJH2024_Sub10_MICT_Pre,0.43193308743253045,0.5086839643045512
SR2019_LM2_Biol_repl_2,,
AST2020_anti-CD3,,
SR2019_MDAMB231_Biol_repl_1,,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,,
KBE2022_Log2_Ex_29_U,,
HS2024_7_B_T1,,
AH2018_LFQ_M_2_X,,
AH2018_LFQ_IT_4_N,,
CK2022_15 200-1,,
RM2024_Intensity D4-1___2,,0.5217028544652473
JJ2018_Ratio H/M normalized,,
JJ2018_Ratio M/L normalized pP3___1,,
KBE2022_Log2_Ex_34_T,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,
LY2019_P2+,,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,
CK2022_2 200-1,,
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,,
RN2012_H01,,
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,0.44299480430596416,0.5317644763563428
KS2014_Intensity pY_E5_3,,
MM2018_Ratio H/L replicate 3,,
EP2017_Pervanadate R#1 normalized log2 ratio,,
HS2024_8_B_T3,0.4436481320406141,
YA2020_Reporter_intensity_Cancer_No.3,,0.5200741906691891
KBE2022_Log2_Ex_44_U,,
WZ2023_Pe_010_20min,,
KS2014_Intensity pY_C6,0.44894974273385013,
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,,
RB2022_3_PreStrength,0.45707418457155885,0.5259811171564546
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,,
KS2014_Intensity C1,0.4491447295475593,
FSO2013_Ratio H/M normalized Rep3___1,,0.5216497961072393
AH2018_SILAC_M_3_C,,
RKK2015_TNF-α+IKKb/TNF-α,,
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,,
AH2018_SILAC_M_2_X,,
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,,
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,,
PG2020_Intensity 6h_C,,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,
JJ2018_Ratio M/L normalized pP1___1,,
AH2018_LFQ_M_3_N,,
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,,
CK2022_15 16-1,,
CK2022_3 16-1,,
LY2019_P4-,,
FSO2013_Ratio H/L normalized Rep3___2,,
KS2014_Intensity pY_PV2,,
HS2024_3_I_N2,,
GF2025_P8_Adh,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,
GF2025_P5_Sph,,
CK2022_10 16-1,,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,0.5227108472438128
NJH2024_Sub2_HIIT_Mid,,0.5220102556708177
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,0.43084569895155267,0.499769570378732
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,0.4427579345362766,0.5327843748762456
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,,
SAS2015_AZD/DMSO_Exp2,,
IMM2018_normalised rep. int. CDK5L-1,,
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,,
EJN2021_2_Ex_Basal,0.4340369763822011,0.5303592725455784
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,,0.5195872989076631
AR2021_L41 10 μM,,
CF2017_EOC 2,,0.5338104358463333
RB2022_6_PostEndurance,,0.5227511555210417
AH2018_SILAC_1_N,,
NJH2024_Sub10_HIIT_Pre,0.4242240713564534,0.4834182977166087
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,,
RB2022_7_PreSprint,0.45111936963420785,0.5316831905520301
NJH2024_Sub2_MICT_Pre,,0.534047043555012
HS2024_3_PD_T2,,
CK2022_6 16-1,,
ZX2022_CB treated Replicate 1,,
BS2014_Log2(Ratio H/L normalized Rep_3),,
TM2022_mock.12h.C,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,,
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,,0.5361821576920811
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,,
AR2021_L41 1 μM,,
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,,
NJH2025_Sub10_MICT_Pre,0.43193308743253045,0.5086839643045512
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,
ZX2022_Control Replicate 3,,
KS2014_Intensity C4,0.44580729970906685,
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,,
NJH2025_Sub9_MICT_Pre,,0.5267775614902107
RCJD2014_20min_1,,
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,,
HS2024_7_B_T2,,
SAS2015_PLX/DMSO_Exp3,,
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,0.5220102556708177
AH2018_LFQ_M_3_C,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,
YA2020_Reporter_intensity_Cancer_No.2,,0.5273305906115415
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,0.45660777703119676,0.5364880809341704
AH2018_SILAC_IT_3_C,,
WZ2023_Pu_025_10min,,
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,,
FSO2013_Ratio M/L normalized Rep3___1,,0.528708852322377
SR2019_JIMT1_Biol_repl_4,,
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,,
CF2017_EOC 4,,
JJ2018_Ratio H/L normalized pP1___1,,
WZ2023_Pe_010_30min,,
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,,
KS2014_Intensity C6,0.44501885128440816,
ZQ2022_N3,,
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,,
NJH2024_Sub7_MICT_Pre,,0.5306754872079975
ZX2022_Control Replicate 1,,
JJ2018_Ratio H/M normalized pP1,,
CK2022_16 40-1,,
AH2018_SILAC_IT_2_C,,
CK2022_5 40-1,,
AH2018_LFQ_3_X,,
UK2020_UA_3,,
LY2019_P7-,,
GF2025_P5_Adh,,
RB2022_1_PostStrength,,0.525714160281389
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,,0.5124612763162295
SR2019_HCC1954_Biol_repl_3,,
CR2017_Ratio Replicate 2.2,,
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,,
ZQ2022_C1,,
CR2017_Ratio Replicate 2.1,,
PG2020_Intensity CT_B,,
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,,
KS2014_Intensity pY_E5_1,,
JW2021_Before_3,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,,
NJH2025_Sub9_HIIT_Pre,,0.5274775809306662
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,,
AH2018_LFQ_3_C,,
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,0.4291905327751146,0.5107251368626421
AH2018_LFQ_M_3_X,,
YA2020_Reporter_intensity_Cancer_No.4,,0.5322205780395385
KS2014_Intensity pY_E5_2,,
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,,
RB2022_2_PreEndurance,,0.5284932773569044
JW2021_Before_1,,
KBE2022_Log2_Ex_25_T,,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,,
FR2021_Intensity.H,,
CK2022_14 16-1,,
AST2020_anti-CD3+PDL2,,
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,,
KS2014_Intensity pY_N1,,
RB2022_1_RecoveryEndurance,,0.5327598696260681
FSO2013_Ratio H/M normalized Rep1___2,,
HS2024_8_I_T1,,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,,
AH2018_TMTMS2_1_X,,
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,,
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,
NJH2025_Sub8_MICT_Mid,0.4326729128733707,0.5152312514621831
EJN2021_5_Ex_Ins,0.4213506169400741,0.5294083201654871
HS2024_6_I_N2,,
HH2022_Reporter intensity 4,,
RBK2021_1326T Late,,
TM2022_mock.12h.B,,
NJH2024_Sub12_MICT_Pre,0.4427956365372473,0.5346679386913026
RCJD2014_15min_3,,
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,,
HS2024_4_I_T3,,0.5100172292048477
AH2018_SILAC_1_X,,
PG2020_Intensity 10h_B,,
AH2018_TMTMS3_1_X,,
CF2017_FTE 14,,0.5267447241348886
NJH2024_Sub13_HIIT_Post,0.4369352256901916,0.5246423191802538
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,0.5303384550412181
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,,
SR2019_HCC1419_Biol_repl_3,,
KBE2022_Log2_Ex_14_T,,
EP2017_Untreated R#2 normalized log2 ratio,,
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,,
HS2024_5_I_N2,0.43841590387710866,
SAS2015_PLX/AZD_Exp3,,
EP2017_Pervanadate R#2 log2 ratio,,
AS2011_Ratio H/L Normalized RNAi_2_1,,
